KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcosa (ACA) Shares Outstanding (Weighted Average) (2017 - 2026)

Arcosa's Shares Outstanding (Weighted Average) history spans 10 years, with the latest figure at $49.0 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 0.62% to $49.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $49.0 million, a 0.62% increase, with the full-year FY2025 number at $48.9 million, up 0.62% from a year prior.
  • Shares Outstanding (Weighted Average) hit $49.0 million in Q1 2026 for Arcosa, roughly flat from $48.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for ACA hit a ceiling of $49.0 million in Q1 2026 and a floor of $48.2 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $48.6 million across 5 years, with a median of $48.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.62% in 2023 and later rose 0.21% in 2024.
  • Tracing ACA's Shares Outstanding (Weighted Average) over 5 years: stood at $48.2 million in 2022, then increased by 0.62% to $48.5 million in 2023, then increased by 0.21% to $48.6 million in 2024, then grew by 0.62% to $48.9 million in 2025, then grew by 0.2% to $49.0 million in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for ACA at $49.0 million in Q1 2026, $48.9 million in Q4 2025, and $48.9 million in Q3 2025.